Table 3:
Variables | HR | 95% CI LB |
95% CI UB |
p |
---|---|---|---|---|
ICI therapy: | ||||
Long (≥24wk) vs. short <24wk) ICI duration | 0.55 | 0.23 | 1.33 | 0.19 |
Platinum status at ICI initiation: | ||||
Sensitive vs. resistant/refractory | 0.59 | 0.26 | 1.36 | 0.22 |
Prior Chemo Lines: (continuous variable) | 1.19 | 1.04 | 1.36 | 0.012 |
ICI, immune checkpoint inhibitor